(Q28304837)

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Regulation of receptor trafficking by GRKs and arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

When 7 transmembrane receptors are not G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Regulation of actin-based cell migration by cAMP/PKA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Cardiac GPCRs: GPCR signaling in healthy and failing hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Transcriptional regulation by cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Molecules in focus: diacylglycerol kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Membrane trafficking of G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

ARF proteins: roles in membrane traffic and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Regulation of arrestin-3 phosphorylation by casein kinase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The human thyrotropin receptor is predominantly internalized by beta-arrestin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

N-formyl peptide receptors internalize but do not recycle in the absence of arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Ubiquitin-dependent down-regulation of the neurokinin-1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Integrating signals from RTKs to ERK/MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Seven-transmembrane-spanning receptors and heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Myocyte adrenoceptor signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

beta-arrestins: traffic cops of cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015

Functional specialization of beta-arrestin interactions revealed by proteomic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.015